Navigation Links
'Good' bacteria could save patients from infection infection by deadlier ones

Can it be that the stress on the use of antiseptics and antibiotics in hospitals is actually putting patients at a greater risk of suffering fatal bacterial infection?

Yes, argues Mark Spigelman, a visiting professor at the Sanford F. Kuvin Center for the Study of Infectious and Tropical Diseases at the Hebrew University of Jerusalem's Faculty of Medicine. Prof. Spigelman points to a recent BBC report on the poor record of bacterial infections in patients (the worst in Europe) in British public hospitals, especially involving the deadly MRSA (methacillin resistant staphylococcus aureus) bacteria. Despite being around for 40 years, these bacteria are still basically found only in hospitals. The question Spigelman asks is why?

Spigelman, who is also a visiting professor at University College London, argues in an article appearing in the current online edition of the Annals of the Royal College of Surgeons of England that the stress on antibiotics and scrubbing with antiseptic soap may actually open an avenue for the more virulent forms of bacteria to attack patients. This is so because these "preventive" measures destroy beneficial bacteria, while at the same time the more "nasty" bacteria are often able to survive by adapting themselves to the pharmacological means used against them.

Since different strains of bacteria do not generally occupy the same surfaces, it would be better, argues Spigelman, to allow the harmless or "good" bacteria to live in the hospital environment, thus creating a kind of natural protection against the deadlier strains.

To test his hypothesis, Spigelman suggests experimenting with antibiotic-free hospitals in which harmless bacteria would be free to exist and there would be no environmental "incentive" for the more virulent strains to develop. Any patients needing antibiotics would be transferred to hospitals where they are in use. Doctors in the antibiotic-free hospitals would not enter and treat patients
'"/>

Source:The Hebrew University of Jerusalem


Page: 1 2

Related biology news :

1. Anti-bacterial additive widespread in U.S. waterways
2. A bacterial genome reveals new targets to combat infectious disease
3. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
4. Scientists discover that host cell lipids facilitate bacterial movement
5. Family trees of ancient bacteria reveal evolutionary moves
6. Drug-resistant bacteria on poultry products differ by brand
7. Programmable cells: Engineer turns bacteria into living computers
8. NASA links nanobacteria to kidney stones and other diseases
9. Substance protects resilient staph bacteria
10. Physiological effects of reduced gravity on bacteria
11. Anammox bacteria produce nitrogen gas in oceans snackbar
Post Your Comments:
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
(Date:5/20/2013)... Minnesota Medical School researchers from the Masonic Cancer Center, ... Tumor Program, have developed a new mouse model of ... to discover new genes and gene pathways driving this ... week in the journal Nature Genetics . , ... lab of David Largaespada, Ph.D., professor in the Medical ...
(Date:5/20/2013)... DIEGO (May 20, 2013) - A novel ... headline the groundbreaking research that will be unveiled at ... Conference (NBC). The meeting takes place Monday, May 20 ... Hotel and Marina. , "The main goal of ... fight against a pathogen that causes the disease", explained ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4U of M researchers develop model for better testing, targeting of MPNST 2Germ-fighting vaccine system makes great strides in delivery 2
... parts of the shark and are often removed from the body, ... practice, many countries allow the fins to be landed detached from ... per cent of the total shark catch. New University of British ... A study published this week in the journal ...
... to their doctor for a blood test generally has to ... of uncertainty can make patients anxious especially in critical ... it takes so long for laboratories to analyze samples is ... Each sample must be accompanied by meticulous records, so lab ...
... Md. (March 1, 2012)The American Physiology Society (APS) has announced ... experimental animals and the sex or gender of humans used ... 13 peer-reviewed journals. This notable requirement for all research study ... be presented in an editorial, " In Pursuit of Scientific ...
Cached Biology News:Law that regulates shark fishery is too liberal: UBC study 2'Labor der Zukunft' -- Tomorrow's laboratory technology 2'Labor der Zukunft' -- Tomorrow's laboratory technology 3APS issues new policy requiring identification of sex or gender in reporting scientific research 2APS issues new policy requiring identification of sex or gender in reporting scientific research 3
(Date:5/21/2013)... The Formulate Fusion Fabric Display ... and marketing teams looking for a fully-functional package for their ... “everything you’ll need to put together a stunning and eye-catching ... a number of displays and accessories that can be quickly ... 20 feet in size. These components vary from kit to ...
(Date:5/20/2013)... -- , Collaboration with the U.S. ... in treatment of mastitis , Major ... begin in the second half 2013 ... Limited (ASX: POH, OTCQX: PPGNY) will collaborate with ... (ARS) to develop and trial products targeting the serious ...
(Date:5/20/2013)... Pa (PRWEB) May 20, 2013 Oven ... with ramp/soak capabilities. The 5R6-900 benchtop controller has ... the device can be plugged into the wall as ... power supply. This distinctive detail makes the device unique, ... , The laboratory temperature controller can also be used ...
(Date:5/20/2013)... -- Today, at the American Psychiatric Association (APA) Meeting ... James McGough , M.D., M.S., principal investigator and ... Neuroscience and Human Behavior and David Geffen ... California Los Angeles (UCLA), and director of clinical teaching ... at UCLA, presented the results of a Phase I ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
... People Living with ... Fibromyalgia -, INDIANAPOLIS, Oct. ... Martha Beck, one day became a seemingly,endless cycle of widespread pain, fatigue, ... answer to the painful,symptoms she was experiencing before she finally received a ...
... Data on Ceftaroline, a Novel, Broad-Spectrum Cephalosporin in,Development ... and,Community Acquired Pneumonia (CAP), WASHINGTON, Oct. 27, ... presented a detailed analysis of CANVAS I, a,globally ... 48th,Annual Interscience Conference on Antimicrobial Agents and Chemotherapy ...
... Today to ... Discuss Results, BIRMINGHAM, ... announced results of an,exploratory Phase 2 trial of intravenous (i.v.) peramivir, ... The Phase 2 trial compared the efficacy and,safety of five days ...
Cached Biology Technology:From Pain to Unexpected Fame: One Woman's Journey to Know Fibro 2From Pain to Unexpected Fame: One Woman's Journey to Know Fibro 3From Pain to Unexpected Fame: One Woman's Journey to Know Fibro 4From Pain to Unexpected Fame: One Woman's Journey to Know Fibro 5Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 2Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 3Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 4Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 5Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 6Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 7Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 8BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 2BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 3BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 4BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 5BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 6
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Recombinant Mouse MMP-9, CF...
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
Biology Products: